Uncertainty in the R2 Calibration Curve for High Iron Concentration

肝活检 校准 活检 再现性 统计 校准曲线 核医学 医学 数学 计算机科学 放射科 检出限
作者
John C. Wood,Eamon K. Doyle,Nilesh R. Ghugre,Thomas D. Coates
出处
期刊:Blood [Elsevier BV]
卷期号:134 (Supplement_1): 3541-3541 被引量:1
标识
DOI:10.1182/blood-2019-128886
摘要

Introduction: MRI assessment of liver iron concentration (LIC) has become the standard of care for monitoring iron chelation strategies. The Ferriscan R2 quantification of LIC has been validated against 338 biopsies in two large cohorts, demonstrates good interstudy reproducibility, and has strong quality control practices. However, its cost remains a challenge for many institutions, making iron measurements by R2* acquisitions more attractive. Several studies comparing LIC by R2* and by Ferriscan R2 have identified substantial bias between R2* and R2 LIC estimates. We postulated that the original Ferriscan R2 calibration overestimates LIC at high iron concentrations, causing the disagreement between the two techniques. Methods: We identified three studies comparing single echo R2 to liver biopsy (362 biopsies). We used a publicly available digital capture program(www.arizona-software.ch/graphclick) to capture the values of R2 for each liver iron concentration level. We fit the data to the existing FDA-approved calibration and compared Bland Altman agreement to liver biopsy against two other calibration curves. The first was data-derived from the aggregate liver biopsy results using a linear fit in log transformed LIC and R2 coordinates (resulting in a Power Law fit). The second was derived from a spline fit to data generated from previously published Monte Carlo simulation model from our laboratory. This model generates "synthetic" R2-iron pairs over the entire physiological range of iron overload, using ideal mathematical approximations to the MRI imaging physics. Results: Panel A demonstrates R2-LIC pairs for the aggregate liver biopsy data and the three evaluated R2-iron calibration curves. Using Bland-Altman analysis, both the Power Law (0.5 ± 4.9 mg/g) and Simulation (1.7 ± 5.1 mg/g) calibrations had 17-22% lower variance than the Ferriscan calibration (-1.1 ± 6.2 mg/g), p<0.0001 by two sample variance test. More importantly, the predicted LIC values diverge dramatically for R2 values greater than 155 Hz (roughly 14 mg/g) (Panel B). For example, a R2 value of 300 Hz will yield an estimated LIC of 48 mg/g by Ferriscan but only 34 mg/g and 32.5 mg/g by the Power Law and Simulation calibrations respectively. Discussion: These data suggest that Ferriscan overestimates true liver iron concentration for R2 values exceeding 155 Hz, with the differences growing geometrically. The calibration error is sufficient to completely explain the differences between LIC by R2* and Ferriscan R2 described in previously studies. Importantly, any future attempt to "calibrate" R2* or other MRI methods against Ferriscan need to account for this bias. Fortunately, the clinical impact of the observed calibration bias is manageable. Patients with LIC below 14 mg/g are being accurately risk stratified. Patients with LIC greater than 14 mg/g in their liver are universally at high risk and should be treated aggressively, regardless. Serial trends in LIC-R2 values also lessen the impact of calibration bias. Both Ferriscan and R2* LIC estimates and provide accurate estimates of chelator efficiency on an annual basis. Further, both Ferriscan and liver R2* LIC estimates are more accurate than liver biopsy in tracking changes in total body iron concentration. However, hematologists should treat Ferriscan predicted LIC values of more than 14 mg/g with appropriate caution and integrate the predicted LIC values with the patient's entire clinical picture to avoid over-reacting to large changes in predicted LIC. ACKNOWLEDGEMENTS This work supported by the National Institutes of Health, Diabetes, Digestive and Kidney Diseases (1R01DK097115-01A1). DISCLOSURES Dr. Wood serves as a consultant to Apopharma, Biomedinformatics, Bluebirdbio, Celgene, Ionis Pharmaceuticals, Imago Biosciences, Silence Therapeutics, and World Care Clinical. Figure Disclosures Wood: National Institutes of Health: Research Funding; Celgene: Consultancy; Apopharma: Consultancy; WorldcareClinical: Consultancy; BluebirdBio: Consultancy; Imago Biosciences: Consultancy; BiomedInformatics: Consultancy; Philips Healthcare: Research Funding. Coates:celgene: Consultancy, Honoraria, Other: steering committee of clinical study; vifor: Consultancy, Honoraria; apo pharma: Consultancy, Honoraria, Speakers Bureau; agios pharma: Consultancy, Honoraria.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
个性乐儿完成签到,获得积分10
刚刚
香蕉觅云的应助被luchong采纳,获得10
刚刚
刚刚
HM完成签到,获得积分10
1秒前
中国科研第一烂完成签到,获得积分10
1秒前
2秒前
安静完成签到 ,获得积分10
2秒前
刘超D完成签到 ,获得积分10
2秒前
2秒前
2秒前
充电宝的应助被海伦采纳,获得10
2秒前
Mr完成签到,获得积分10
2秒前
Orange的应助被捉闰土的猹采纳,获得10
3秒前
852的应助被活力的香采纳,获得10
3秒前
3秒前
hhb完成签到,获得积分10
3秒前
huangyi完成签到 ,获得积分10
3秒前
Ww完成签到,获得积分10
3秒前
王少雄发布了新的文献求助10
3秒前
chy完成签到 ,获得积分10
4秒前
4秒前
HM发布了新的文献求助10
4秒前
4秒前
4秒前
风吹麦浪的应助被NAN采纳,获得10
5秒前
5秒前
奕奕完成签到,获得积分10
5秒前
123的应助被xiatian采纳,获得15
5秒前
6秒前
myz发布了新的文献求助10
6秒前
风趣怀亦发布了新的文献求助10
6秒前
歪歪发布了新的文献求助10
6秒前
想吃芝士荔枝烤鱼完成签到,获得积分10
7秒前
笨笨垣发布了新的文献求助10
7秒前
未了发布了新的文献求助10
7秒前
小猫完成签到 ,获得积分10
7秒前
小亦雪发布了新的文献求助10
7秒前
Wangguagua完成签到 ,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253